Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
To learn more about how the delivery of medical information affects therapy choices for participants with advanced forms of cancer.
Full description
Primary Objectives • To examine how provision of medical information (risks, benefits, time toxicity, prognosis, oncologists' recommendation, and costs) affects preference for palliative systemic therapy in participants with advanced cancer.
Secondary Objective
• To examine how different options of medical information (risks/benefits, time toxicity, prognosis, oncologists' recommendation, and costs) affect preference for palliative systemic therapy in participants with advanced cancer.
Exploratory Objective
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Diagnosis of advanced solid tumor (i.e. metastatic, relapsed, and/or incurable disease) or aggressive lymphoma.
Exclusion criteria
400 participants in 1 patient group
Loading...
Central trial contact
David Hui, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal